RecruitingNot ApplicableNCT07258563

The TASTY-steering Study

Taste Steering in Patients With Cancer Who Are Treated With Chemotherapy: a Multicentre Randomized Intervention Trial


Sponsor

University Medical Center Groningen

Enrollment

201 participants

Start Date

Jun 6, 2025

Study Type

INTERVENTIONAL

Conditions

Summary

This is a multicentre non-blinded randomised intervention trial with a parallel cluster design. The multicentre study will be performed at 12 hospitals in the Netherlands. A parallel cluster design per hospital was selected to prevent contact between participants in the same hospital who are randomised into different study arms. Such contact may result in bias as it may allow for patients in the control arm to be informed about elements of taste steering. To examine the effect of at-home taste steering versus standard care on food enjoyment, the obtained results and outcomes will be measured 1) at baseline before chemotherapy is started, 2) at week 0 when taste or smell alterations occur, and 3) after 6 weeks. The taste steering will take place at home. The control group will receive usual care. Questionnaires will be filled in online at home, while taste and smell tests and saliva collection will be conducted either at home or in the hospital during regular visits. Patients in both study arms are contacted by their dietitian every 3 weeks. Some hospitals have implemented elements of taste steering. However, these elements are focused on patients who are admitted to the hospital, and therefore only interfere to a limited extent with the present study that is directed at patients managing their taste alterations at home. Experience with the Smaakpupil tool indicates that the algorithm reaches saturation after 3-4 weeks. Therefore, an intervention period of 6 weeks has been selected.


Eligibility

Min Age: 18 YearsMax Age: 70 Years

Plain Language Summary

Simplified for easier understanding

This study investigates whether changes in taste and smell caused by chemotherapy are linked to nutritional intake and eating habits in cancer patients. Participants who develop taste changes during chemotherapy may be offered additional support to maintain good nutrition. **You may be eligible if...** - You are 18 to 70 years old - You are about to start chemotherapy for metastatic triple negative breast cancer, metastatic testicular cancer, or stage II–IV diffuse large B-cell lymphoma - You are able to eat and drink normally - You are not heavily reliant on nutritional supplements (less than 50% of your daily calories from supplements) **You may NOT be eligible if...** - You are pregnant - You already have taste or smell problems before chemotherapy - You previously received radiation to the head or neck - You are receiving nutrition through a feeding tube or intravenously Talk to your doctor to see if this trial is right for you.

This summary was AI-generated to explain the trial in plain language. It is not medical advice. Always discuss eligibility with your doctor before enrolling in a clinical trial.

Interested in this trial?

Get notified about updates and connect with the research team.

Interventions

BEHAVIORALTaste steering

To examine the effect of at-home taste steering versus standard care on food enjoyment, the obtained results and outcomes will be measured 1) at baseline before chemotherapy is started, 2) at week 0 when taste or smell alterations occur, and 3) after 6 weeks. The taste steering will take place at home. The control group will receive usual care. Questionnaires will be filled in online at home, while taste and smell tests and saliva collection will be conducted either at home or in the hospital during regular visits. Patients in both study arms are contacted by their dietitian every 3 weeks.


Locations(11)

Amsterdam UMC

Amsterdam, Netherlands

Rijnstate Ziekenhuis

Arnhem, Netherlands

Van Weel-Bethesda Ziekenhuis

Dirksland, Netherlands

Ziekenhuisvoorzieningen Gelderse Vallei

Ede, Netherlands

University Medical Center Groningen

Groningen, Netherlands

Martini Ziekenhuis

Groningen, Netherlands

Radboud University Medical Center

Nijmegen, Netherlands

Ikazia Ziekenhuis

Rotterdam, Netherlands

Ommelander Ziekenhuis Groningen

Scheemda, Netherlands

Maxima Medisch Centrum

Veldhoven, Netherlands

Isala Klinieken

Zwolle, Netherlands

View Full Details on ClinicalTrials.gov

For the most up-to-date information, visit the official listing.

Visit

NCT07258563